The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: A randomized double-blind trial

Transfusion

Volumn 53, Issue 4, 2013, Pages 777-782

  Santos, Maria Cristina ^a   Sá, Cynthia ^a   Gomes Jr, Saint Clair ^a   Camacho, Luiz Antonio ^a   Moreira, Maria Elisabeth ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; SERUM ALBUMIN;

ABSENCE OF SIDE EFFECTS; ALLOIMMUNITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAZIL; CONTROLLED STUDY; COOMBS TEST; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MOTHER; NEWBORN HEMOLYTIC DISEASE; NEWBORN PERIOD; OUTCOME ASSESSMENT; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BRAZIL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; MALE; PHOTOTHERAPY; PREGNANCY; RH ISOIMMUNIZATION; TREATMENT OUTCOME;

EID: 84876101476     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03827.x     Document Type: Article

References (17)

1. Mollison PL, Engelfriet CP, Contreras M,. Haemolytic disease of the fetus and the newborn. In:, Mollison PL, Engelfriet CP, Contreras M, editors. Blood transfusion in clinical medicine. Oxford: Blackwell Scientific Publications; 1997. p. 390-423.
2. Bowman J,. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997; 21: 39-44.
3. van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH,. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 2004; 83: 731-7.
4. Sá CAM, Moreira ME, Santos MCP, De Carvalho M,. Adverse events related to exchange transfusion in newborn infants with hemolytic disease: ten years of experience Rev. Paul Pediatr 2009; 2: 168-72.
5. Jackson JC,. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99: 1-6.
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
7. Alcock GS, Liley H,. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;(3): CD003313.
8. Gottstein R, Cooke RW,. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-F10.
9. Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E,. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999; 88: 216-9.
10. Smits-Wintjens VE, Walther FJ, Rath ME, Lindenburg IT, Te Pas AB, Kramer CM, Oepkes D, Brand A, Lopriore E,. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011; 127: 680-6.
11. Ballow M,. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011; 127: 315-23.
12. O'Brien PC, Fleming TR,. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56.
13. Dagoglu T, Ovali F, Samanci N, Bengisu E,. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995; 23: 264-71.
14. Nasseri F, Mamouri GA, Babaei H,. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 2006; 27: 1827-30.
15. Rubo J, Albrecht K, Lasch P, Laufkötter E, Leititis J, Marsan D, Niemeyer B, Roesler J, Roll C, Roth B, Von Stockhausen HB, Widemann B, Wahn V,. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992; 121: 93-7.
16. Pishva N, Madani A, Homayoon K,. Prophylactic intravenous immunoglobulin in neonatal immune hemolytic jaundice. Iranian J Med Sci 2000; 25: 129-33.
17. Elalfy MS, Elbarbary NS, Abaza HW,. Early intravenous immunoglobulin (two-dose regimen) in the management of severe Rh hemolytic disease of newborns-a prospective randomized controlled trial. Eur J Pediatr 2011; 170: 461-7.